Bipolar and Related Disorders: Clinical Trials

1,678 trials for Bipolar and Related Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1052 completed, 193 unknown, 171 recruiting, 116 terminated. 641 Not applicable, 232 Phase 4, 229 Phase 3, 177 Phase 2, 76 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable641Completed 367, Unknown 95, Recruiting 91, Terminated 29, Not yet recruiting 22, Active not recruiting 18, Withdrawn 11, Enrolling by invitation 5, Suspended 3
Phase 4232Completed 164, Terminated 23, Unknown 18, Withdrawn 12, Recruiting 11, Not yet recruiting 2, Active not recruiting 1, Suspended 1
Phase 3229Completed 177, Terminated 22, Unknown 10, Recruiting 9, Withdrawn 6, Active not recruiting 4, Suspended 1
Phase 2177Completed 115, Terminated 21, Recruiting 14, Withdrawn 11, Unknown 10, Active not recruiting 4, Not yet recruiting 2
Phase 176Completed 51, Terminated 9, Unknown 6, Recruiting 5, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Suspended 1
Early Phase 112Completed 5, Terminated 2, Unknown 2, Withdrawn 2, Active not recruiting 1

Follow Bipolar and Related Disorders: new trials by email Literature Review of Bipolar and Related Disorders trials Research Report on Bipolar and Related Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
Semaglutide (SEMA), Exercise module, Anti-inflammatory diet module - Severe Mental Illness, Depression / Major Depressive Disorder
Not applicableNot yet recruitingLudwig-Maximilians - University of Munich1402028-10-012026-05-14
Targeted Alternating Current and Cognitive Training Intervention for Cognitive Control in Bipolar Disorders
Soterix 1x1 tES mini-CT - Bipolar Disorder, Bipolar and Related Disorders
Not applicableNot yet recruitingVA Office of Research and Development1382027-06-012026-09-28
Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders, Major Depressive Disorder is Suspected to Have the Greatest Burden by 2030,Kynurenine Pathway is Major Route Through Which the Essential Amino Acid Tryptophan is Metabolised and Activated in Time of Stress and Immune Activation.
Major Depressive Disorder (MDD)
Not yet recruitingSohag University902027-03-142026-08-20
Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment
Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder)
Not yet recruitingInternational University of La Rioja302027-02-012026-11-06
Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications
repetitive transcranial magnetic stimulation (rTMS) - Schizophrenia, Bipolar Disorder
Not applicableNot yet recruitingCentral South University4002027-01-012026-03-04
N-Acetylcysteine for Bipolar and Alcohol Use Disorders
N-acetyl cysteine, Placebo - Bipolar Disorder, Alcohol Use Disorder
Phase 2Not yet recruitingMedical University of South Carolina702027-01-012026-11-03
Empagliflozin Adjunctive Therapy in Bipolar Depression
Empagliflozin (EMPA) - Bipolar Disorder, Bipolar Depression
Not applicableRecruitingUniversity of Sao Paulo202026-11-122026-11-16
Functional Magnetic Resonance Imaging Study of Inhibitory Control in Bipolar Disorder and Major Depressive Disorder
Analysis of inhibitory control - Bipolar Disorder, Major Depressive Disorder
Not applicableRecruitingCHU de Reims1202026-11-032026-11-13
Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar Disorder
Lurasidone (Latuda) - Bipolar Disorder Depression
Phase 4Not yet recruitingMartin Lan602026-11-012026-09-08
BAROMETRE : Study on the Prognosis and Course of Individuals With Bipolar Spectrum Disorder
Structured clinical follow-up and psychometric assessment - Bipolar Disorder (BD)
Not yet recruitingUniversity Hospital, Angers602026-11-012026-10-14
Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment Area
Ketogenic foodstuffs, Standard of Care Oral antipsychotics, Standard of care long acting injectable medication for bipolar disorder - Bipolar Disorder
Not applicableNot yet recruitingUniversity of Alabama at Birmingham1002026-11-012026-10-07
A Mobile App to Support Mood, Daily Routines and Medication Adherence in Adults With Severe Mental Illness
MoodSync, Standard care - Severe Mental Illness, Bipolar Disorder
Not applicableNot yet recruitingAlexandria University602026-11-012026-10-16
Evaluating the PolarUs App in People With Bipolar Disorder
PolarUs Mobile App - Bipolar Disorder (BD), Quality of Life (QOL)
Not applicableNot yet recruitingUniversity of British Columbia5042026-11-012026-10-22
Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood Disorders
Major Depressive Disorder, Bipolar Disorder
Not yet recruitingAssiut University2402026-11-012026-11-02
Validation of Wearable Core Body Temperature-Based Circadian Rhythm Digital Biomarkers
Mood Disorders, Major Depressive Diorder
Not yet recruitingKorea University Anam Hospital2002026-11-012026-10-29
Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling
LCHF Ketogenic Diet, Diet-as-Usual (DAU) - Schizophrenia, Schizophrenia and Related Disorders
Not applicableRecruitingStanford University1202026-10-192026-11-16
Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants
NRL-1004 2.5 mg, ZYPREXA IM 10mg, NRL-1004 5.0 mg - Healthy Adult Participants
Phase 1Not yet recruitingNeurelis, Inc.242026-10-162026-11-06
Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory Models
Peripheral blood sampling for PBMC isolation - Bipolar Disorder (BD), Bipolar Disorder (BPD)
Not applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS202026-10-012026-07-29
Cognition and Affective Research in China
Neurodegenerative Disease, Dementia
Not yet recruitingXuanwu Hospital, Beijing30002026-10-012026-09-22
Effect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental Illness
Occupational Therapy Group Intervention - Schizophenia Disorder, Severe Mental Illness
Not applicableNot yet recruitingBiruni University502026-10-012026-10-16

Showing 20 of 1678. Sign in to see all of them.

Narrower conditions

Bipolar Disorder (1672)  ·  Schizophrenia (348)  ·  Depression (294)  ·  Depressive Disorder, Major (253)  ·  Psychotic Disorders (221)  ·  Mania (116)  ·  Mood Disorders (113)  ·  Mental Disorders (108)  ·  Depressive Disorder (85)  ·  Anxiety Disorders (63)  ·  Stress Disorders, Post-Traumatic (36)  ·  Depressive Disorder, Treatment-Resistant (33)  ·  Alcoholism (32)  ·  Substance-Related Disorders (32)  ·  Cognitive Dysfunction (31)

Broader conditions

Mental Disorders (1570)  ·  Mood Disorders (1565)  ·  Behavior (456)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (405)  ·  Behavioral Symptoms (341)  ·  Depressive Disorder (253)  ·  Pathological Conditions, Signs and Symptoms (235)  ·  Nervous System Diseases (213)  ·  Signs and Symptoms (210)  ·  Neurologic Manifestations (167)  ·  Neurobehavioral Manifestations (148)  ·  Chemically-Induced Disorders (83)  ·  Nutritional and Metabolic Diseases (61)  ·  Neurodevelopmental Disorders (52)

Interventions

Quetiapine Fumarate (77)  ·  Lithium (64)  ·  Valproic Acid (56)  ·  Lamotrigine (49)  ·  Olanzapine (47)  ·  Aripiprazole (44)  ·  Risperidone (40)  ·  Lithium Carbonate (37)  ·  Therapeutics (35)  ·  ziprasidone (35)  ·  Ketamine (32)  ·  Lurasidone Hydrochloride (26)  ·  Transcranial Magnetic Stimulation (22)  ·  Cognitive Behavioral Therapy (16)  ·  Sugars (16)

Sponsors

Massachusetts General Hospital (63)  ·  AstraZeneca (47)  ·  National Institute of Mental Health (NIMH) (41)  ·  Mclean Hospital (33)  ·  Stanford University (23)  ·  University of Pittsburgh (22)  ·  University of Texas Southwestern Medical Center (22)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (21)  ·  University Hospitals Cleveland Medical Center (21)  ·  VA Office of Research and Development (21)  ·  Eli Lilly and Company (19)  ·  New York State Psychiatric Institute (19)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (18)  ·  Centre for Addiction and Mental Health (17)  ·  Dartmouth-Hitchcock Medical Center (17)

Countries

United States (835)  ·  Canada (135)  ·  France (98)  ·  China (75)  ·  Spain (52)  ·  Denmark (49)  ·  United Kingdom (44)  ·  Turkey (Türkiye) (43)  ·  Germany (40)  ·  Brazil (34)  ·  Russia (33)  ·  South Korea (28)  ·  Taiwan (28)  ·  Ukraine (25)  ·  Bulgaria (23)

Top investigators

Martha Sajatovic, MD (12)  ·  Joseph Biederman, MD (8)  ·  Keming Gao, MD, PhD (7)  ·  Amit Anand, MD (6)  ·  Benjamin I Goldstein, MD, PhD (6)  ·  Janet Wozniak, MD (6)

Results publications

PMID 34523118, PMID 41401709, PMID 31969269, PMID 32476658, PMID 34689733, PMID 41130742, PMID 42393474, PMID 32336984, PMID 32792252, PMID 32942346, PMID 33677183, PMID 33915374, PMID 39520655, PMID 41017591, PMID 14702256, PMID 18588360, PMID 19210948, PMID 19956459, PMID 20854181, PMID 21095016, PMID 22198448, PMID 23473546, PMID 23511717, PMID 23609405, PMID 23761037, PMID 23945460, PMID 24111980, PMID 24329543, PMID 25083802, PMID 25978742, PMID 26462799, PMID 26598478, PMID 26730454, PMID 27215976, PMID 27529375, PMID 27780336, PMID 28446253, PMID 28832750, PMID 29017067, PMID 29105003, PMID 29931798, PMID 31279534, PMID 31344528, PMID 31957686, PMID 32046986, PMID 34131914, PMID 34510411, PMID 34623633, PMID 34817851, PMID 35377567

NIH funding

2016 (7), 2023 (4), 2004 (2), 2019 (2), 2025 (2), K01MH112876 (2), K23DA050808 (2), K23MH065599 (2), KL2TR000440 (2), R01MH060353 (2), R01MH064662 (2), R01MH077210 (2), R34MH078967 (2), R34MH117198 (2), 1IK2RX003069-01A2 (1)